 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

A platform presentation will feature Dr. Enze Liu from the Indiana University School of Medicine sharing findings from a study on the use of optical genome mapping (OGM) to detect structural variants...

Bionano Announces Presentations Featuring OGM Utility Across Blood Cancer Research at the American Society of Hematology (ASH) Annual Meeting

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Bionano Genomics announces study on OGM's role in diagnosing FSHD

SAN DIEGO, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a publication demonstrating the use of optical genome mapping (OGM) to identify structural...

Bionano Announces Publication Demonstrating Utility of OGM to Assess Genome Integrity of CRISPR-Edited Cells as Part of Gene Therapy Development

Bionano Genomics, Inc. (BNGO) Presents at Stifel Healthcare Conference (Transcript...

Bionano Genomics, Inc. (BNGO) Presents at Stifel Healthcare Conference (Transcript)

QUEBEC CITY, Canada, Nov. 15, 2023 (GLOBE NEWSWIRE) -- LeddarTech , an automotive software company that provides patented disruptive low-level sensor fusion and perception software technology for...

LeddarTech Appoints Chris Stewart as Chief Financial Officer

A corporate workshop session will feature Dr. Alka Chaubey, Bionano's chief medical officer, Dr. Panieh Terraf from Memorial Sloan Kettering Cancer Center, Dr. Ravindra Kolhe from Augusta University...

Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual Meeting

Q3 2023 revenue was $9.3 million, which represents a 29% increase over Q3 2022Installed base of Saphyr systems totaled 301 as of September 30, 2023, which represents a 39% increase over the number...

Bionano Reports Third Quarter 2023 Results and Highlights Recent Business Progress

Bionano Genomics announces OGM was included in a medical school textbook

SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that optical genome mapping (OGM) was included for the first time in Thompson and Thompson...

Thompson and Thompson Genetics and Genomics in Medicine Includes OGM in Latest Edition, Notes Workflow's Performance and Ability to Detect More SVs than LRS at Lower Cost

SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, November 8, 2023, at 4:30 p.m...

Bionano to Report Third Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 8, 2023

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.

Market Cap	$59.04M
Volume (M)	4,107.00
52-Wk High	$22.40
52-Wk Low	$1.19

Period	Estimated	Reported	Surprise	Result
Q3'23	$-0.97	$-3.22	-232.07%	MISSED
Q2'23	$-1.07	$-1.24	-16.02%	MISSED
Q1'23	$-0.10	$-1.20	-1047.94%	MISSED
Q4'22	$-0.11	$-0.12	-10.31%	MISSED
Q3'22	$-0.11	$-0.11	2.98%	BEAT

BNGO Bionano Genomics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals